Contact REPROCELL

Peripheral Blood Mononuclear Cells as Translational Tools in Drug Development

Explore the crucial role of Peripheral Blood Mononuclear Cells in drug development, enhancing immunotherapy, biomarker discovery, and personalized medicine.

01 October 2026

More Than Half a Century of Drug Development Attrition: Why Better Human-Relevant Models Are Needed

Explore the urgent need for human-relevant models in drug development to reduce high clinical attrition rates and improve patient outcomes.

03 September 2026

Scaling iPSC Manufacturing: From Cell Line Development to Clinical-Production

Learn how to scale iPSC manufacturing from clinical cell line development and gene editing to GMP cell banking and bioreactor expansion.

27 August 2026

Why PBMCs matter in gene and cell therapies

Explore the vital role of PBMCs in gene therapy and translational research, highlighting their importance in understanding immune responses and treatment efficacy.

23 July 2026

Empowering the Future of Gene Editing with StemEdit OC-1 Protein

Discover the innovative StemEdit OC-1 Protein, a generative AI-designed gene-editing enzyme that enhances genome engineering with improved safety and efficiency.

20 July 2026